MSI Financial Services’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

MSI Financial Services’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-100	Closed	-$1K	–	4114
2016 Q2	$1K	Hold	100	–	–	﹤0.01%	3817
2016 Q1	$2K	Hold	100	–	–	﹤0.01%	3624
2015 Q4	$2K	Hold	100	–	–	﹤0.01%	3520
2015 Q3	$2K	Hold	100	–	–	﹤0.01%	2833
2015 Q2	$4K	Hold	100	–	–	﹤0.01%	2584
2015 Q1	$3K	Hold	100	–	–	﹤0.01%	2653
2014 Q4	$1K	Hold	100	–	–	﹤0.01%	2571
2014 Q3	$2K	Buy	+100	New	+$2.04K	﹤0.01%	2443

Other funds holding CBMG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

MSI Financial Services's CBMG Position: Q3 2016 in Review

MSI Financial Services sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q3 2016, closing a stake of 100 shares — an estimated $1K sold.

MSI Financial Services first reported a position in CBMG in Q3 2014 and held it in 8 quarters. The position peaked at $4K in Q2 2015. 36 funds tracked by Wall St. Rank hold CBMG as of Q3 2016.

MSI Financial Services reported no remaining Cellular Biomedicine Group, Inc. position as of Q3 2016 after selling out during the quarter.
MSI Financial Services sold 100 Cellular Biomedicine Group, Inc. shares in Q3 2016, an estimated $1K.
MSI Financial Services first reported a position in Cellular Biomedicine Group, Inc. in Q3 2014 and held it in 8 quarters.
MSI Financial Services's Cellular Biomedicine Group, Inc. position peaked at $4K in Q2 2015.
36 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q3 2016.

Based on MSI Financial Services's 13F filing for Q3 2016, filed 13 Oct 2016.